Finanzielle Vergleiche Lupin Limited

Aktien

Markt geschlossen - Bombay S.E. Andere Börsenplätze 11:00:46 16.02.2026			% 5 Tage	Veränd. 1. Jan.
2’220.50 ^INR	+0.97%		+2.41%	+5.14%

13.02.	Lupin Limited, Q3 2026 Earnings Call, Feb 13, 2026
13.02.	Biocon strebt Umsatzsprung mit Einführung generischer Abnehmmedikamente an	RE

Sektor:

Region:

X-Achse:

Hauptkonkurrenten

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	Umsatz (Y-1)	Nettogewinn (Y-1)	EBIT-Marge (Y-1)	ROE (Y-1)	ROA (Y-1)	Verschuldungsgrad (Y-1)
LUPIN LIMITED	2.66 Mrd.	14.45%	18.09%	20.96%	12.34%	0.37x
ELI LILLY AND COMPANY	65.18 Mrd.	31.67%	41.84%	103.86%	22.92%	0.95x
JOHNSON & JOHNSON	94.19 Mrd.	28.46%	32.23%	34.62%	14.26%	0.73x
ABBVIE INC.	56.33 Mrd.	7.59%	41.43%	263.08%	13.34%	2.56x
ROCHE HOLDING AG	77.58 Mrd.	20.94%	35.49%	47.65%	15.43%	0.66x
ASTRAZENECA PLC	54.07 Mrd.	13.01%	31.31%	32.11%	12.51%	1.47x
NOVARTIS AG	56.67 Mrd.	24.64%	38.62%	38.4%	16.33%	1.02x
MERCK & CO., INC.	64.17 Mrd.	26.68%	36.46%	46.35%	17.38%	0.86x
NOVO NORDISK A/S	48.59 Mrd.	33.14%	41.3%	60.7%	20.31%	0.69x
AMGEN INC.	33.42 Mrd.	12.24%	44.96%	177.29%	11.36%	2.33x
GILEAD SCIENCES, INC.	28.75 Mrd.	1.67%	29.63%	27.6%	9.57%	1.48x
PFIZER INC.	63.63 Mrd.	12.62%	34.24%	19.99%	8.05%	1.52x
VERTEX PHARMACEUTICALS INCORPORATED	12 Mrd.	32.94%	43.85%	27.07%	16.41%	-1.18x
BRISTOL-MYERS SQUIBB COMPANY	48.19 Mrd.	14.64%	30.37%	72.08%	7.72%	1.83x
GSK PLC	39.28 Mrd.	8.21%	29.16%	48.09%	10.97%	1.22x
SANOFI	42.53 Mrd.	13.98%	27.61%	11.75%	4.43%	0.68x
CHUGAI PHARMACEUTICAL CO., LTD.	7.45 Mrd.	33.09%	46.3%	22%	18.71%	-1.74x
TAKEDA PHARMACEUTICAL COMPANY LIMITED	30.6 Mrd.	2.36%	7.48%	1.5%	1.19%	3.6x
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	3.83 Mrd.	22.64%	26.77%	14.73%	13.49%	-2.98x
BAYER AG	48.25 Mrd.	-5.48%	11.66%	15.32%	-2.25%	3.2x
Durchschnitt	43.87 Mrd.	17.47%	32.44%	54.26%	12.22%	0.96x
Gewichteter Durchschnitt nach Marktkapitalisierung	58.28 Mrd.	21.44%	36.43%	75.48%	15.25%	1.08x